Vaxcyte

Recent news

• Rating change
  BTIG Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $89
  Market Newswire · 2026/7/30
• Rating change
  BofA Securities Maintains Vaxcyte(PCVX.US) With Buy Rating, Cuts Target Price to $134
  Market Newswire · 2025/10/3
• Rating change
  Guggenheim Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $116
  Market Newswire · 2026/7/14
• Rating change
  BofA Securities Maintains Vaxcyte(PCVX.US) With Buy Rating, Announces Target Price $133
  Market Newswire · 2026/8/6
• Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $110
  Market Newswire · 2026/9/25
• Rating change
  TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Raises Target Price to $75
  Market Newswire · 2026/2/25
• Rating change
  Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Raises Target Price to $110
  Market Newswire · 2026/1/7
• Guggenheim Maintains Vaxcyte(PCVX.US) With Buy Rating, Raises Target Price to $125
  Market Newswire · 2026/10/5
• Mizuho Securities Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $163
  Market Newswire · 2026/10/5
• BofA Securities Maintains Vaxcyte(PCVX.US) With Buy Rating
  Market Newswire · 2026/9/28
• Rating change
  BTIG Maintains Vaxcyte(PCVX.US) With Buy Rating, Cuts Target Price to $85
  Market Newswire · 2025/10/16
• Rating change
  Mizuho Securities Maintains Vaxcyte(PCVX.US) With Buy Rating, Announces Target Price $163
  Market Newswire · 2025/8/18
• Rating change
  Evercore Maintains Vaxcyte(PCVX.US) With Buy Rating
  Market Newswire · 2026/5/21
• Rating change
  Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $90
  Market Newswire · 2025/12/9
• Jefferies Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $146
  Market Newswire · 2026/10/5
• Rating change
  TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $75
  Market Newswire · 2026/8/6
• Rating change
  Goldman Sachs Maintains Vaxcyte(PCVX.US) With Hold Rating, Maintains Target Price $67
  Market Newswire · 2026/2/26
• Rating change
  BTIG Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $85
  Market Newswire · 2026/2/13
• Rating change
  A Quick Look at Today's Ratings for Vaxcyte(PCVX.US), With a Forecast Between $67 to $133
  Market Newswire · 2026/2/26
• Rating change
  TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $50
  Market Newswire · 2025/11/5

Headlines are aggregated automatically and are not independently verified or edited by our team.